Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1987-8-19
pubmed:abstractText
Sorcin (soluble resistance-related calcium-binding protein), an acidic (pI = 5.7) protein (Mr approximately 20 kDa) previously designated V19, was originally identified in cells selected for high levels of resistance to vincristine. Two-dimensional gel electrophoresis and/or Western blot techniques now show sorcin to be overproduced in cells selected for resistance to actinomycin D (QUA/ADj), colchicine (CHRC5), and adriamycin (BE(2)-C/ADR). Not all cell lines selected for resistance to these drugs overproduced sorcin; e.g. cells of an independently selected actinomycin D-resistant subline of QUA, QUA/ADsx, did not contain increased amounts of sorcin. Sorcin was purified by preparative gel electrophoresis from QUA/ADj cells and used to generate specific antiserum in chickens. By Western blot analyses the antiserum was shown to recognize sorcin in QUA/ADj and in vincristine-resistant mouse and Chinese hamster lung, colchicine-resistant Chinese hamster ovary, and adriamycin-resistant human neuroblastoma lines. Low level expression of the protein was detectable in control, drug-sensitive cells. Direct binding assays with 45Ca2+ showed that sorcin was a calcium-binding protein. QUA/ADj cells contained increased numbers of double minute chromosomes (DMs), cytogenetic indicators of gene amplification. As found for two other multidrug-resistant sublines, sorcin overproduction in QUA/ADj cells may be the result of amplification of the sorcin-encoding gene. The overproduction of this protein in multidrug-resistant cells of various species implies that sorcin plays a role in expression of the resistant phenotype.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0006-2952
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2373-80
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:3606647-Animals, pubmed-meshheading:3606647-Calcium, pubmed-meshheading:3606647-Calcium-Binding Proteins, pubmed-meshheading:3606647-Colchicine, pubmed-meshheading:3606647-Cricetinae, pubmed-meshheading:3606647-Cricetulus, pubmed-meshheading:3606647-Dactinomycin, pubmed-meshheading:3606647-Doxorubicin, pubmed-meshheading:3606647-Drug Resistance, pubmed-meshheading:3606647-Female, pubmed-meshheading:3606647-Fibroblasts, pubmed-meshheading:3606647-Gene Amplification, pubmed-meshheading:3606647-Humans, pubmed-meshheading:3606647-Immunoelectrophoresis, pubmed-meshheading:3606647-Lung, pubmed-meshheading:3606647-Mice, pubmed-meshheading:3606647-Mice, Inbred C57BL, pubmed-meshheading:3606647-Neoplasm Proteins, pubmed-meshheading:3606647-Neoplasms, Experimental, pubmed-meshheading:3606647-Neuroblastoma, pubmed-meshheading:3606647-Ovary, pubmed-meshheading:3606647-Vincristine
pubmed:year
1987
pubmed:articleTitle
Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.